Company profile
Lineage Cell Therapeutics
A clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.
- Industry
- Biotechnology Research
- Employees
- 34
- Headquarters
- Carlsbad, CA
- Founded
- 1990
- LinkedIn followers
- 6,989
- Office locations
- 2
Lineage Cell Therapeutics company summary
Lineage Cell Therapeutics is a company in the Biotechnology Research industry, headquartered in Carlsbad, CA, founded in 1990. On LinkedIn the company has around 34 employees and 6,989 followers. The company lists 2 office locations.
What technology does Lineage Cell Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical assets include (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase I/IIa development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase I/IIa development for the treatment of acute spinal cord injuries; and (iii) VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells currently in Phase I development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com.
Where is Lineage Cell Therapeutics located?
Lineage Cell Therapeutics lists 2 office locations.
Compare companies similar to Lineage Cell Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Lineage Cell Therapeutics lineagecell.com | Biotechnology Research | 34 | 1990 | Carlsbad, CA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Lineage Cell Therapeutics
What does Lineage Cell Therapeutics do?
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical assets include (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase I/IIa development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase I/IIa development for the treatment of acute spinal cord injuries; and (iii) VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells currently in Phase I development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com.
How many employees does Lineage Cell Therapeutics have?
Lineage Cell Therapeutics has around 34 employees on LinkedIn.
Where is Lineage Cell Therapeutics headquartered?
Lineage Cell Therapeutics is headquartered in Carlsbad, CA.
Where does Lineage Cell Therapeutics have offices?
Lineage Cell Therapeutics lists 2 office locations, including Carlsbad, CA, US; Alameda, CA, US.
When was Lineage Cell Therapeutics founded?
Lineage Cell Therapeutics was founded in 1990.
Build a lead list from companies like Lineage Cell Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.